Antidotes for nonchemotherapy drug extravasation
Extravasated drug | Classification: vesicant or irritant | Immediate topical treatment | Antidote |
---|---|---|---|
Acyclovir2,5-7 | Irritant or vesicant; alkaline agent (pH 11) | Cooling | Hyaluronidase |
Aminophylline2,4 | Vesicant; alkaline agent (pH 8–10) | Warming | Hyaluronidase |
Amiodarone1,6,8 | Vesicant; acidic agent (pH 3.5–4.5) | Warming | Hyaluronidase |
Amphotericin B4 | Vesicant; acidic agent (pH 5–7) | Cooling | Hyaluronidase; for liposomal, consider flushout instead |
Ampicillin4 | Vesicant; hyperosmolar agent | Warming | Hyaluronidase |
Calcium chloride 10%2,4 | Vesicant; hyperosmolar agent | Warming | Early-onset: hyaluronidase Delayed-onset: sodium thiosulfate |
Dantrolene4 | Vesicant; alkaline agent (pH 9.5–10.3) | Warming | Hyaluronidase |
Dextrose 10%–50%4 | Vesicant; hyperosmolar agent | Warming | Hyaluronidase |
Dobutamine2,4 | Vesicant; vasopressor | Warming | First-line: phentolamine Second-line: terbutaline/topical nitroglycerin |
Dopamine2,4 | Vesicant; vasopressor | Warming | First-line: phentolamine Second-line: terbutaline/topical nitroglycerin |
Doxycycline4 | Vesicant; acidic agent (pH 1.8–3.3) | Warming | Hyaluronidase |
Epinephrine2,4 | Vesicant; vasopressor | Warming | First-line: phentolamine Second-line: terbutaline/topical nitroglycerin |
Esmolol4 | Vesicant; acidic agent (pH 4.5–6.5) | Warming (no literature support) | Hyaluronidase |
Etomidate2,4 | Irritant (rarely vesicant); hyperosmolar agent | Warming (no literature support) | Hyaluronidase |
Lorazepam4 | Vesicant; hyperosmolar agent | Warming (no literature support) | Hyaluronidase |
Mannitol 20%4 | Vesicant; hyperosmolar agent | Warming | Hyaluronidase |
Metronidazole4 | Vesicant; acidic agent (pH 5.5) | Warming (no literature support) | Hyaluronidase |
Methylene blue4 | Vesicant; vasopressor | Warming (no literature support) | First-line: topical nitroglycerin Second-line: phentolamine or terbutaline |
Nafcilllin4 | Vesicant or irritant | Warming | Hyaluronidase |
Nitroglycerin2 | Vesicant; hyperosmolar agent | Warming or cooling | Hyaluronidase |
Norepinephrine2,4 | Vesicant; vasopressor | Warming | First-line: phentolamine Second-line: terbutaline/topical nitroglycerin |
Parenteral nutrition2,4 | Vesicant; hyperosmolar agent | Warming | Hyaluronidase, nitroglycerin |
Pentobarbital4 | Vesicant; alkaline agent (pH 9–10.5) | Warming | Hyaluronidase |
Phenobarbital2,4 | Vesicant; hyperosmolar agent | Warming (no literature support) | Hyaluronidase |
Phenylephrine2,4 | Vesicant; vasopressor | Warming | First-line: phentolamine Second-line: topical nitroglycerin |
Phenytoin and fosphenytoin2,4 | Vesicant; alkaline agent (pH 10–12) | Warming | Hyaluronidase or nitroglycerin |
Potassium chloride2,4 | Irritant; hyperosmolar agent | Warming | Hyaluronidase |
Potassium phosphate6 | Irritant; hyperosmolar agent | Cooling | Hyaluronidase |
Sodium bicarbonate 8.4%2,4 | Vesicant; hyperosmolar agent | Warming | Hyaluronidase |
Sodium chloride (> 3%)2,4 | Vesicant; hyperosmolar agent | Warming | Hyaluronidase |
Sodium phosphate4 | Vesicant; hyperosmolar agent | Warming | Hyaluronidase |
Penicillin4 | Vesicant | Warming (no literature support) | Hyaluronidase |
Valproate4 | Vesicant | Cooling | Hyaluronidase with washout |
Vancomycin4 | Irritant or vesicant; acidic agent | Warming (no literature support) | Hyaluronidase |
Vasopressin4 | Vesicant; vasopressor | Warming | First-line: topical nitroglycerin Second-line: phentolamine or terbutaline |